Crossmark

A Practical Guide to Modeling and Conducting a Cost-Effectiveness Analysis of Companion Biomarker Tests for Targeted Therapies Using R: Tutorial Paper

Crossref DOI link: https://doi.org/10.1007/s40273-021-01069-8

Published Online: 2021-08-20

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Seo, Mikyung Kelly https://orcid.org/0000-0003-4746-2264
Strong, Mark
License Information

Text and Data Mining valid from 2021-08-20

Version of Record valid from 2021-08-20
More Information

Article History

Accepted: 13 July 2021

First Online: 20 August 2021

Declarations

:

: MKS received a PhD scholarship from the Centre for Cancer Biomarkers (CCBIO), Centre of Excellence at the Faculty of Medicine and Dentistry, University of Bergen. No sources of funding were used to conduct this study or prepare this manuscript.

: Mikyung Kelly Seo and Mark Strong have no conflicts of interest to declare that are directly relevant to the content of this article.

: Not applicable.

: Not applicable.

: Not applicable.

: All data generated or analyzed during this study are included in this published article and its ESM.

: All R codes used in this study are included in this published article and its ESM.

: Mikyung Kelly Seo (MKS) conceived and designed the study. MKS developed the model and R codes, and performed the analysis. Mark Strong (MS) validated the model and R codes. MKS wrote the original manuscript. All authors reviewed and approved the final manuscript.

Document is current

Any future updates will be listed below